Biogen Pharmachem Industries
Biogen Pharmachem Industries Share Price Chart
Biogen Pharmachem Industries last traded at ₹0.26 (2026-10-13). Over the past month the stock moved -3.7%, three months the stock moved -27.8%, year the stock moved -66.2%. Its closing range over 52 weeks is ₹0.26 – ₹0.71, with the latest close 63.4% below the high.
Closing prices up to 2026-10-13.
About Biogen Pharmachem Industries
Incorporated in 1995, Biogen Pharmachem Industries Ltd is in the business of trading in shares and securities.[1]
Business Overview:[1] BPIL is engaged in the business of trading in shares and securities in the present and future markets. It trades in commodities, including agro-based and precious metals, and other goods. The company also provides stock broking and consulting services. In addition, it generates trades and sells wind power
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Biogen Pharmachem Industries reported sales of ₹0.44 crore and net profit of ₹0.22 crore (-83.6%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.44 | 0.22 | 50.00 | 0.22 | 0.00 |
| Mar 2026 | 0.58 | -0.36 | -62.07 | -0.36 | 0.00 |
| Dec 2025 | 0.54 | 0.46 | 85.19 | 0.46 | 0.00 |
| Sep 2025 | 0.00 | -0.39 | – | -0.49 | 0.00 |
| Jun 2025 | 0.00 | -0.20 | – | 1.34 | 0.01 |
| Mar 2025 | 1.35 | 1.18 | 87.41 | 1.18 | 0.02 |
| Dec 2024 | 0.00 | -0.54 | – | -0.31 | 0.00 |
| Sep 2024 | 0.00 | -0.35 | – | -1.00 | -0.01 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | +73.1% | – | – | – | -57.0% | – |
| Operating profit growth | – | – | +59.5% | – | – | – | -130.5% | – |
| Net profit growth | -238.9% | -616.7% | +59.5% | – | – | – | -130.5% | -83.6% |
| EPS growth | -200.0% | – | +100.0% | – | – | – | -100.0% | -100.0% |
| OPM % | – | – | 87.4% | – | – | 85.2% | -62.1% | 50.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Biogen Pharmachem Industries reported sales of ₹2.56 crore (+204.8%) and net profit of ₹0.86 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2.56 | 0.96 | 37.50 | 0.86 | 0.01 |
| Mar 2025 | 0.84 | -0.29 | -34.52 | -0.29 | 0.00 |
| Mar 2024 | 0.79 | 0.36 | 45.57 | 1.93 | 0.03 |
| Mar 2023 | 0.00 | -0.45 | – | 0.46 | 0.01 |
| Mar 2022 | 2.47 | -0.02 | -0.81 | -0.01 | 0.00 |
| Mar 2021 | 1.62 | -1.60 | -98.77 | -1.60 | -0.02 |
| Mar 2020 | 0.00 | -0.12 | – | -0.12 | 0.00 |
| Mar 2019 | 0.95 | 0.00 | 0.00 | 0.00 | 0.00 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +763.6% | -100.0% | – | +52.5% | -100.0% | – | +6.3% | +204.8% |
| Operating profit growth | – | – | – | – | – | – | -180.6% | – |
| Net profit growth | – | – | – | – | – | +319.6% | -115.0% | – |
| EPS growth | – | – | – | – | – | +200.0% | -100.0% | – |
| OPM % | 0.0% | – | -98.8% | -0.8% | – | 45.6% | -34.5% | 37.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
AI Analysis
No AI analysis generated yet for Biogen Pharmachem Industries.
Get Free AI Stock Analysis FREE →Latest News
-
Biogen Pharmachem Industries - 14 penny stocks plunge up to 55% in 2 months. Are you affected? - The Economic Times
-
Biogen Pharmachem Industries - 14 penny stocks plunge up to 55% in 2 months. Are you affected? - The Economic Times
-
Parichay Infrastructure acquires 4.42% stake in Biogen Pharmachem - scanx.trade
-
Biogen Pharmachem Turns Profitable with Net Profit of ₹85.95 Lacs in FY26 - scanx.trade
Frequently Asked Questions
What is Biogen Pharmachem Industries's current stock price?
Biogen Pharmachem Industries shares were last quoted at ₹0.26 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Biogen Pharmachem Industries?
Biogen Pharmachem Industries has a price-to-earnings (P/E) ratio of 0.00 and a price-to-book (P/B) ratio of 0.26. The industry P/E is 39.42.
What is the 52-week high and low of Biogen Pharmachem Industries?
The 52-week high of Biogen Pharmachem Industries is ₹0.77 and the 52-week low is ₹0.25.
What is the market cap of Biogen Pharmachem Industries?
The market capitalisation of Biogen Pharmachem Industries is about ₹29.49 crore.
How did Biogen Pharmachem Industries perform in its latest quarterly results?
In the latest quarter (Jun 2026), Biogen Pharmachem Industries reported sales of ₹0.44 crore and net profit of ₹0.22 crore (-83.6%), compared with the same quarter last year.
Is Biogen Pharmachem Industries a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Biogen Pharmachem Industries has a 3-year ROE of 1.00%, 3-year profit growth of 85.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Which sector does Biogen Pharmachem Industries belong to?
Biogen Pharmachem Industries belongs to the Trading sector.